Delivery Order SPE2DB22D3501-SPE2DB25FXF16
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,468.68 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,153.39 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,305.23 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (30-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitively awarded contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,957.32 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count units) on August 10, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,870.22 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count package) with a firm fixed price arrangement. This competitively awarded, non-set-aside contract was executed on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp valued at $11,144.50 for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,844.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, which is not set-aside, represents a single pharmaceutical procurement under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,813.72 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger pharmaceutical supply...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF16Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,664.02 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract. The award was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with performance of this delivery order taking place at the vendor's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical prime vendor agreement running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. Through this vehicle, AmerisourceBergen Drug Corp supplies customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, reinforcing the company's role as a key vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.7k | 9/8/25 |